MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.gastha.2025.100802

Медицинская библиотека · Gastro hep advances · 2025

Mild Dilatation of the Main Pancreatic Duct Is a Risk Factor for Progression to Pancreatic Cancer in High-Risk Individuals.

Diwan Elizabeth Abou, Saba Helena, Blackford Amanda L, Dbouk Mohamad, Chu Linda, He Jin, Burkhart Richard, Hruban Ralph H, Goggins Michael, Canto Marcia Irene

СтатьяПеревод в очереди

Аннотация

BACKGROUND AND AIMS: Mild dilatation of the main pancreatic duct (MPD) can be an early indicator of an obstructing mass, but its clinical significance in asymptomatic high-risk individuals (HRIs) undergoing surveillance has not been defined. We determined the prevalence and incidence of MPD dilation in HRI and assessed its association with neoplastic progression (to high-grade dysplasia or pancreatic ductal adenocarcinoma (PDAC)) in HRI.

METHODS

We analyzed prospectively collected data from HRIs enrolled in the Cancer of Pancreas Screening cohort studies. We determined the risk of neoplastic progression associated with MPD dilation (defined as ≥4, ≥3, ≥2 mm diameter, in the head, body, tail, respectively) using Cox regression and time-varying covariate analysis. We estimated time-to-progression from baseline endoscopic ultrasound and from baseline duct dilation by the Kaplan-Meier method.

RESULTS

Of 641 HRIs followed for a median 3.6 years (interquartile range 1.9-7.2), 97 (15%) had MPD dilation without evidence of an obstructing mass lesion; 10 of whom (10.3%) were diagnosed with neoplastic progression within a median of 2 years after dilation was first detected. The cumulative probability of high-grade dysplasia/PDAC in HRI with baseline MPD dilation was 16% at 5 years and 26% at 10 years. HRI with any MPD dilation were 2.6 times more likely to progress (P = .05), particularly those with ≥ 3 pancreatic cysts during surveillance (adjusted hazard ratio = 9.07, P < .001).

CONCLUSION

MPD dilation without an apparent obstructing lesion is an independent risk factor for neoplastic progression in HRI.

Для цитирования: Diwan Elizabeth Abou, Saba Helena, Blackford Amanda L, Dbouk Mohamad, Chu Linda, He Jin, Burkhart Richard, Hruban Ralph H, Goggins Michael, Canto Marcia Irene. Mild Dilatation of the Main Pancreatic Duct Is a Risk Factor for Progression to Pancreatic Cancer in High-Risk Individuals.. Gastro hep advances. 2025. DOI: 10.1016/j.gastha.2025.100802.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.